CMXC insider filings

Cell MedX Corp. — 37 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-01-10. Screen CMXC transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CMXC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Cell MedX Corp.

FiledFormInsiderReported transactionsSource
2024-01-104Jeffs David — Chief Executive Officer, Director, 10% ownerGrant/award (A): 73,959,726 @ $0.01 · Purchase (P): 7,500,000 @ $0.01 · Purchase (P): 7,500,000 @ $0.01EDGAR
2024-01-094Vahabzadeh Amir — Director, 10% ownerGrant/award (A): 61,755,148 @ $0.01EDGAR
2024-01-094Yaretz Dwayne — DirectorGrant/award (A): 1,214,285 @ $0.01EDGAR
2024-01-094daCosta Joao — DirectorGrant/award (A): 531,687 @ $0.01EDGAR
2024-01-094JEFFS RICHARD — 10% ownerPurchase (P): 14,372,285 @ $0.01EDGAR
2022-04-084HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 10,000 @ $0.15EDGAR
2022-02-114HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 300 @ $0.18EDGAR
2022-02-084HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 7,000 @ $0.15 · Sale (S): 300 @ $0.18EDGAR
2022-01-074HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 7,500 @ $0.15EDGAR
2022-01-034HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 5,000 @ $0.18EDGAR
2021-12-214HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 5,000 @ $18.20EDGAR
2021-12-174HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 4,654 @ $0.19EDGAR
2021-11-294HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 20,000 @ $0.17EDGAR
2021-09-144HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 10,000 @ $0.20EDGAR
2021-09-104HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 10,000 @ $0.22EDGAR
2021-08-044HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 6,500 @ $0.26EDGAR
2021-08-024HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 10,000 @ $0.26EDGAR
2021-07-294HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 10,000 @ $0.26EDGAR
2021-07-264HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 10,000 @ $0.24 · Sale (S): 351 @ $0.28EDGAR
2021-07-064HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 9,000 @ $0.26EDGAR
2021-06-284HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 8,000 @ $0.25EDGAR
2021-06-254HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 8,000 @ $0.25EDGAR
2021-06-174HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 5,000 @ $0.28 · Sale (S): 5,000 @ $0.29EDGAR
2021-06-154HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 5,000 @ $0.24EDGAR
2021-06-014HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 5,000 @ $0.28EDGAR
2021-04-304HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 10,000 @ $0.27 · Sale (S): 10,000 @ $0.28 · Sale (S): 22,150 @ $0.28EDGAR
2021-04-264HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 25,000 @ $0.26 · Sale (S): 10,000 @ $0.26EDGAR
2021-04-214HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 22,562 @ $0.25 · Sale (S): 27,438 @ $0.25 · Sale (S): 22,562 @ $0.25 · Sale (S): 24,780 @ $0.27EDGAR
2021-04-194HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 23,500 @ $0.22EDGAR
2021-04-074HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 20,000 @ $0.23EDGAR
2021-03-314HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% ownerSale (S): 25,000 @ $0.22EDGAR
2021-03-314HARGREAVES BRADLEY S — VP Technolgy & Operations, Director, 10% ownerSale (S): 18,911 @ $0.27EDGAR
2021-03-314HARGREAVES BRADLEY S — VP Technolgy & Operations, Director, 10% ownerSale (S): 19,700 @ $0.30EDGAR
2021-02-164HARGREAVES BRADLEY S — VP, Technology and Operations, Director, 10% ownerGift (G): 300,000 @ $0EDGAR
2020-09-014HARGREAVES BRADLEY S — VP, Technology and Operations, Director, 10% ownerOption exercise (M): 1,234,855 @ $0.05 · Option exercise (M): 1,234,855 (derivative) @ $0EDGAR
2020-09-014ARNETT JEAN M — 10% ownerOption exercise (M): 1,250,000 @ $0.05 · Option exercise (M): 1,250,000 (derivative) @ $0EDGAR
2020-09-014MCENULTY FRANK — President and CEO, DirectorPurchase (P): 40,000 @ $0.25 · Purchase (P): 40,000 (derivative) @ $0EDGAR

Recent 8-K events — Cell MedX Corp.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-09-088-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-208-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-028-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-03-288-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-02-278-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-01-088-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-058-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-048-K3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-198-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CMXC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs